SLC2A1 and renal cell adenocarcinoma: In addition, CUL2, CDC42, GLUT1 and other proteins, which have been demonstrated to be critical in malignant renal cell carcinoma, were predicted to be downstream target proteins of microRNAs differentially expressed in PMAH patients compared with normal controls.